EcoDrugPlus

Ribosomal Protein L36

Ensembl ID : ENSOKIG00005017187
Gene Symbol: RPL36
1 Cross references
170 Possible Orthologues:

Ribosomal Protein L37

Ensembl ID : ENSOKIG00005039355
Gene Symbol: RPL37
1 Cross references
377 Possible Orthologues:

Ribosomal Protein L37

Ensembl ID : ENSOKIG00005037836
Gene Symbol: RPL37
1 Cross references
419 Possible Orthologues:

Ribosomal Protein L38

Ensembl ID : ENSOKIG00005006247
Gene Symbol: RPL38
3 Cross references
143 Possible Orthologues:

Ribosomal Protein L39

Ensembl ID : ENSOKIG00005031542
Gene Symbol: RPL39
1 Cross references
150 Possible Orthologues:

Ribosomal Protein L39

Ensembl ID : ENSOKIG00005027088
Gene Symbol: RPL39
1 Cross references
150 Possible Orthologues:

Ribosomal Protein L4

Ensembl ID : ENSOKIG00005039641
Gene Symbol: RPL4
3 Cross references
338 Possible Orthologues:

Ribosomal Protein L5

Ensembl ID : ENSOKIG00005014353
Gene Symbol: RPL5
3 Cross references
419 Possible Orthologues:

Ribosomal Protein L5

Ensembl ID : ENSOKIG00005045340
Gene Symbol: RPL5
3 Cross references
420 Possible Orthologues:

Ribosomal Protein L5

Ensembl ID : ENSOKIG00005019365
Gene Symbol: RPL5
3 Cross references
463 Possible Orthologues:

Ribosomal Protein L5

Ensembl ID : ENSOKIG00005027321
Gene Symbol: RPL5
3 Cross references
463 Possible Orthologues:

Ribosomal Protein L7

Ensembl ID : ENSOKIG00005007906
Gene Symbol: RPL7
3 Cross references
487 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).